Johnson & Johnson Basic Information, Manufacturing Base, Sales Area, and Competitors
|
Sr. No. |
Item |
Description |
|
1 |
Company Name |
Johnson & Johnson |
|
2 |
Website |
www.jnj.com |
|
3 |
Established Date |
1886 |
|
4 |
Headquartered |
United States |
|
5 |
Market Position/ History |
Johnson & Johnson company was founded in 1886. The company initially focused on producing sterile surgical dressings and sutures, setting new standards for cleanliness and quality in the medical industry. In 1919, the company opened the Gilmour Plant near Montreal, its first factory outside of the United States. Further, in the 1930s, the company expanded operations to Argentina, Brazil, Mexico, and South Africa. In 2013, the company acquired Aragon Pharmaceuticals, Inc., and in 2014, the company acquired Alios BioPharma, Inc. In course of time, the company has acquired several companies including Actelion, Emerging Implant Technologies GmbH, Momenta Pharmaceuticals and others. Johnson & Johnson operates through its 265 subsidiaries in over 60 countries and serves its products in over 175 countries. |
|
6 |
Sales Area |
Worldwide |
|
7 |
Manufacturing Location |
61 manufacturing facilities across the United States, Europe, Western Hemisphere, excluding the U.S., Africa, Asia and the Pacific |
|
8 |
Ticker |
NYSE: JNJ |
|
9 |
No. of Employees |
~131,900 employees |
|
10 |
Competitors |
|
|
11 |
CEO |
Joaquin Duato |
|
12 |
Ownership Type |
Public |
|
13 |
Contact Information |
One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933 Tel: (732) 524-0400 |
Business Segment/ Overview:
Johnson & Johnson and its subsidiaries (the Company) have approximately 131,900 employees worldwide engaged in the research and development, manufacture, and sale of a broad range of products in the healthcare field. The Company conducts business in virtually all countries of the world with the primary focus on products related to human health and well-being.
Currently, the company is operating under two business segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on the following therapeutic areas: Immunology (e.g., rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease and psoriasis), Infectious Diseases (e.g., HIV/AIDS), Neuroscience (e.g., mood disorders, neurodegenerative disorders and schizophrenia), Oncology (e.g., prostate cancer, hematologic malignancies, lung cancer and bladder cancer), Cardiovascular and Metabolism (e.g., thrombosis, diabetes and macular degeneration) and Pulmonary Hypertension (e.g., Pulmonary Arterial Hypertension). Further, The MedTech segment includes a broad portfolio of products used in the Interventional Solutions, Orthopaedics, Surgery and Vision categories. Interventional Solutions include electrophysiology products (Biosense Webster) to treat heart rhythm disorders, the heart recovery portfolio (Abiomed) which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock, and Neurovascular care (Cerenovus) that treats hemorrhagic and ischemic stroke. Johnson & Johnson Vision products include ACUVUE Brand contact lenses and TECNIS intraocular lenses for cataract surgery. These products are distributed to wholesalers, hospitals and retailers, and used predominantly in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics.
Micro Invasive Glaucoma Surgery MIGS Device Product Types Specification
|
Product |
Description |
|
BAERVELDT Glaucoma Implants |
The BAERVELDT BG 103-250, BAERVELDT BG 101-350 and BAERVELDT Pars Plana BG 102-350 Glaucoma Implants Provide pressure control with a minimally invasive BAERVELDT Glaucoma Implant. Its fenestration system is designed to control bleb height and volume while a patented larger surface area enhances IOP control. When traditional glaucoma therapy can’t help the rising IOP, provide control with a BAERVELDT Glaucoma Implant. Minimally Invasive
BAERVELDT BG 103-250 Glaucoma Implant Specifications
BAERVELDT BG 101-350 Glaucoma Implant Specifications
BAERVELDT Pars Plana BG 102-350 Glaucoma Implant Specifications
|
Author's Detail:
Sneha Mali /
LinkedIn
Sneha Mali is a research analyst working in various domains including the Consumer Goods, market research and transport & logistics and her primary responsibility is to conduct thorough research on various subjects and provide valuable insights to support client requirements. Her knowledge of research methodologies, and data mining which enables me to analyze large data sets, draw meaningful conclusions, and communicate them effectively.Sneha stay up-to-date with the latest research trends, methodologies, and technologies to ensure that her research is accurate, relevant, and impactful.
In her current role, Sneha is committed to continuous learning and staying abreast of emerging trends in research methodologies. Regular participation in workshops, webinars, and industry conferences ensures that her skills remain sharp and relevant. She have demonstrated ability to transform complex data sets into clear and concise narratives that inform key business strategies. Collaborating with cross-functional teams.Sneha remains an invaluable asset in the dynamic landscape of market research.